22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR Therapeutics
- Author
- Moira Gunn
- Published
- Wed 14 Dec 2022
- Episode Link
- https://share.transistor.fm/s/f505e2cb
Cancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO, talks about just two of the candidates in its pipeline: One is for Non-small cell lung cancer and another for ER+ breast cancer, with these and other clinical trials enrolling now.
